These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 13106417

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Sulfurated preparations and iodine in surgery of thyrotoxicoses].
    WIJNBLADH H.
    Nord Med; 1952 Apr 25; 47(17):551-4. PubMed ID: 14947991
    [No Abstract] [Full Text] [Related]

  • 24. Agranulocytosis occurring during 1-methyl-2-mercaptoimidazole therapy treated with cortisone and donor bone marrow injection.
    AINSLIE EH, HARLEY HC.
    Can Serv Med J; 1955 Apr 25; 11(7):502-8. PubMed ID: 13240627
    [No Abstract] [Full Text] [Related]

  • 25. [THE ROLE OF MERCASOLYL COMBINED WITH RESERPINE IN THE PREOPERATIVE CARE OF PATIENTS WITH THYROTOXICOSIS].
    NARYCHEV AA, NARYCHEVA KK.
    Klin Med (Mosk); 1965 Jan 25; 43():68-73. PubMed ID: 14344798
    [No Abstract] [Full Text] [Related]

  • 26. Repetitive monomorphic ventricular tachycardia as a manifestation of suboptimally treated thyrotoxicosis.
    Chandra PA, Vallakati A, Chandra AB, Pednekar M, Ghosh J.
    Am Heart Hosp J; 2010 Jan 25; 8(2):E113-4. PubMed ID: 22022738
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Thyrotoxicosis-an uncommon cause of heart failure.
    Froeschl M, Haddad H, Commons AS, Veinot JP.
    Cardiovasc Pathol; 2005 Jan 25; 14(1):24-7. PubMed ID: 15710288
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [10 years of experience in the treatment of thyrotoxicosis with antithyroid preparations].
    KLIACHKO VR.
    Probl Endokrinol Gormonoter; 1960 Jan 25; 6():57-65. PubMed ID: 13756795
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Our experiences with ambulatory therapy of hyperthyroidism with favistan].
    LEVNTAL Z, PUTNIK M, GLIGOROVA N.
    Med Glas; 1960 Feb 25; 14():140-3. PubMed ID: 14416352
    [No Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of methimazole ointment for patients with hyperthyroidism.
    Wu X, Liu H, Zhu X, Shen J, Shi Y, Liu Z, Gu M, Song Z.
    Environ Toxicol Pharmacol; 2013 Nov 25; 36(3):1109-12. PubMed ID: 24148291
    [Abstract] [Full Text] [Related]

  • 34. [Immediate results with 1-methyl-2-mercaptoimidazole in hyperthyroidism].
    ROJAS MUJICA G, DIAZ DE VALDES H.
    Rev Med Chil; 1952 Mar 25; 80(3):159-63. PubMed ID: 14942114
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Clinical aspects of hyperthyroidism in aged patients].
    Ansaldi E, Farias M, Scaglione L, Berni P, Malvicino F.
    Minerva Med; 1989 Sep 25; 80(9):969-76. PubMed ID: 2478926
    [Abstract] [Full Text] [Related]

  • 37. [Experiences with methimazole and carbimazole in the treatment of hyperthyroidism].
    PULVER W, BRUNDLER R.
    Ther Umsch; 1957 Jan 25; 14(1):1-10. PubMed ID: 13409311
    [No Abstract] [Full Text] [Related]

  • 38. A four-year study of the treatment of hyperthyroidism with methimazole.
    McGAVACK TH, CHEVALLEY J, KENIGSBERG S, PEARSON S.
    Bulletin NY Med Coll; 1953 Jan 25; 16():58-85. PubMed ID: 13160721
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.